Acute Hepatic Porphyria
7 clinical trials · Condition
◉ Watch Acute Hepatic Porphyria
| Record | Firm | Date |
|---|---|---|
| Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome (NCT05344599) | Vanderbilt University Medical Center | 2022-01-19 |
| Prevalence of Acute Hepatic Porphyria (NCT04923516) | Association pour la Recherche en Medecine Interne | 2021-08-23 |
| ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) (NCT04883905) | Alnylam Pharmaceuticals | 2021-04-26 |
| INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP (NCT03547297) | Alnylam Pharmaceuticals | 2018-05-29 |
| ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) (NCT03338816) | Alnylam Pharmaceuticals | 2017-11-16 |
| Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria (NCT04056481) | Alnylam Pharmaceuticals |
Track Acute Hepatic Porphyria automatically
Every clearance here is in the API, with alerts when new ones post.